A BILL for an Act to amend and reenact subsection 3 of section 54-35-26 and section 57-40.2-03.3 of the North Dakota Century Code, relating to evaluation of economic development tax incentives and the use tax exemption for raw materials, single-use product contact systems, and reagents used for biologic manufacturing; to repeal section 57-39.2-04.19 of the North Dakota Century Code, relating to the sales tax exemption for raw materials, single-use product contact systems, and reagents used for biologic manufacturing; and to provide an effective date.
House Bill 1571 aims to amend and reenact specific sections of the North Dakota Century Code concerning the evaluation of economic development tax incentives and the use tax exemption for certain materials used in biologic manufacturing. The bill proposes a systematic analysis of various economic development tax incentives every six years, including those related to manufacturing, agriculture, and renewable energy. Additionally, it seeks to repeal the existing sales tax exemption for raw materials and reagents used in biologic manufacturing, which would affect the financial landscape for businesses in this sector.
If enacted, this bill would significantly alter the landscape of economic development tax incentives in North Dakota. The mandated six-year review process would ensure that tax incentives remain relevant and effective, potentially leading to adjustments in which incentives are offered. The repeal of the sales tax exemption for biologic manufacturing materials could lead to increased costs for companies in that industry, potentially affecting their competitiveness and investment decisions in North Dakota.
The general sentiment surrounding HB1571 appears to be mixed, as indicated by its failure to pass. While some stakeholders may support the systematic review of tax incentives as a means to ensure accountability and effectiveness, others may oppose the repeal of the sales tax exemption, viewing it as a detrimental move for the biologic manufacturing sector. The lack of committee discussions or votes further suggests that the bill did not garner sufficient support.
Notable points of contention include the repeal of the sales tax exemption for raw materials used in biologic manufacturing, which has raised concerns among industry stakeholders about increased operational costs. Proponents of the bill argue for the need for regular evaluations of tax incentives to ensure they serve their intended purpose, while opponents fear that the repeal could hinder growth in a critical sector of the economy.